Form 13-F position report

ASENSUS SURGICAL INC COM (DE)

Reported by MORGAN STANLEY

ASXC CUSIP 04367G103 Manager CIK 0000895421

Reported 129,150 shares, down 291,647 (69.3%) from the prior quarter.

Reported value -41.8%; share count -69.3% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q1 2023
Shares 129,150 Quarter-end amount reported
Reported value $84,981 Fair value at quarter end
Consecutive quarters held 9 Through Q1 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 3799000
2021-12-31 2029000
2022-03-31 1077000
2022-06-30 260000
2022-09-30 186000
2022-12-31 146058
2023-03-31 84981
2023-06-30 71779
2023-09-30 55026
2023-12-31 58619
2024-03-31 26970
2024-06-30 33317
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

13 quarters
Quarterly reported position history for ASENSUS SURGICAL INC COM (DE) held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -100,053 (-100.0%) 0 $0 2024-11-14
Q2 2024 Reduced 100,053 -17,208 (-14.7%) < 0.01% $33,317 2024-08-14
Q1 2024 Reduced 117,261 -66,556 (-36.2%) < 0.01% $26,970 2024-05-15
Q4 2023 Reduced 183,817 -19,983 (-9.8%) < 0.01% $58,619 2024-02-13
Q3 2023 Added 203,800 +61,663 (43.4%) < 0.01% $55,026 2023-11-15
Q2 2023 Added 142,137 +12,987 (10.1%) < 0.01% $71,779 2023-08-14
Q1 2023 Reduced 129,150 -291,647 (-69.3%) < 0.01% $84,981 2023-05-15
Q4 2022 Added 420,797 +5,965 (1.4%) < 0.01% $146,058 2023-02-14
Q3 2022 Reduced 414,832 -238,411 (-36.5%) < 0.01% $186,000 2022-11-14
Q2 2022 Reduced 653,243 -1,064,156 (-62.0%) < 0.01% $260,000 2022-08-15
Q1 2022 Reduced 1,717,399 -110,841 (-6.1%) < 0.01% $1,077,000 2022-05-13
Q4 2021 Reduced 1,828,240 -225,514 (-11.0%) < 0.01% $2,029,000 2022-02-14
Q3 2021 Added 2,053,754 +1,098,253 (114.9%) < 0.01% $3,799,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

90 managers reported ASENSUS SURGICAL INC COM (DE) for Q1 2023.

Managers reporting ASENSUS SURGICAL INC COM (DE) in Q1 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Unchanged 11,436,860 0 < 0.01% $7,525,454 9 qtrs
BlackRock Inc Reduced 3,655,484 -3,625 < 0.01% $2,405,308 9 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 2,267,381 +80,678 < 0.01% $1,491,936 9 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 1,923,900 -351,952 < 0.01% $1,266,000 9 qtrs
MASTERS CAPITAL MANAGEMENT LLC New 1,843,000 +1,843,000 0.06% $1,212,694 1 qtr
STATE STREET CORPORATION Added 957,129 +140,000 < 0.01% $629,791 9 qtrs
GSA CAPITAL PARTNERS LLP Reduced 749,800 -218,236 0.05% $493,000 5 qtrs
UBS Group AG Reduced 536,970 -28,688 < 0.01% $353,326 9 qtrs
AlphaCentric Advisors LLC New 500,000 +500,000 0.23% $329,000 1 qtr
NORTHERN TRUST CORPORATION Added 439,615 +24,432 < 0.01% $289,267 9 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2023
Filed
May 15, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
109,167
Shared
0
None
19,983

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.